비만 수술 기기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Obesity Surgery Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,853,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,009,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,655,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 비만 수술 기기 시장에 대한 상세한 조사 보고서를 발표하여 시장 촉진요인, 동향, 기회, 과제 등 시장 역학에 대한 상세한 인사이트를 제공했습니다. 이 보고서는 시장 구조와 향후 전망에 대한 철저한 이해를 제공하는 것을 목표로 하며, 경쟁 환경에서 우위를 점하고자 하는 업계 관계자들의 요구에 부응합니다.

주요 인사이트

• 세계 시장 수익(2022년) : 19억 달러
• 추정 시장 가치(2033년) : 32억 달러
• 세계 시장 성장률(2022-2033년 CAGR) : 6.0%

비만 수술 기기 세계 시장 - 조사 범위

비만 수술 기기 시장은 비만 치료를 위한 외과 수술에 사용되는 기기의 생산 및 유통에 초점을 맞추고 있습니다. 이러한 기기는 전 세계적으로 증가하는 비만, 특히 소아 및 성인의 비만 증가를 관리하는 데 매우 중요하며, 당뇨병, 심혈관질환, 특정 암과 같은 비만과 관련된 건강 문제에 대한 의료 부문의 대응에 필수적입니다.

시장 성장 촉진요인:

어린이 및 성인의 비만 발생률 증가

전 세계적으로 소아 및 성인 비만 유병률의 증가는 비만 수술 기기에 대한 수요를 견인하는 중요한 요인으로 작용하고 있습니다. 식습관 변화와 운동량 감소로 인해 비만율이 급증하고 있으며, 이는 앞으로도 시장 성장의 주요 촉진제가 될 것으로 예상됩니다. 예를 들어, 유니세프(UNICEF)의 2022년 세계 비만 아틀라스(World Obesity Atlas)에 따르면, 2030년까지 인도에서만 2,700만 명 이상의 어린이가 비만이 될 것으로 예상됩니다. 이 놀라운 통계는 효과적인 비만 관리 전략의 필요성을 강조하고 있으며, 이는 비만 수술 기기 세계 시장에 박차를 가하고 있습니다.

의료비 지출 증가 및 인식 개선

전 세계적으로, 특히 신흥국과 선진국의 의료비 증가로 인해 비만 관리와 치료에 대한 관심이 높아지고 있습니다. 1인당 의료비 증가로 인해 개인과 의료 서비스 제공자가 양질의 치료 옵션을 추구함에 따라 첨단 비만 수술 기기의 채택을 촉진할 것으로 예상됩니다. 또한 비만과 관련된 당뇨병, 심혈관질환, 뇌졸중과 같은 심각한 건강 위험에 대한 비만인의 인식이 높아짐에 따라 비만 수술 기기에 대한 수요가 증가할 것으로 예상됩니다.

정부 캠페인과 최소침습 수술

비만과 그 결과에 대한 인식을 높이기 위한 정부 주도의 캠페인도 시장 성장에 기여하고 있습니다. 인도 마하라슈트라 주 정부의 지원을 받는 인도의 라파로오베소 센터(LaparoObeso Center)의 프로젝트와 같은 노력은 외딴 지역 주민들에게 비만과 당뇨병에 대해 교육하는 것을 목표로 합니다. 중국에서도 중국 영양학회의 비만 예방 관리 부서는 비만 위기를 해결하기 위한 인식 개선 캠페인을 전개하고 있습니다. 또한, 최소침습적 체중 감량 수술에 대한 선호도가 높아지는 것도 시장을 더욱 촉진할 것으로 예상됩니다.

시장의 과제

높은 생산 비용과 제한된 재정적 지원

시장의 잠재력에도 불구하고 비만 수술기구의 높은 연구개발 및 생산비용이 큰 문제점으로 지적되고 있습니다. 임상시험을 포함한 연구개발 활동에 필요한 막대한 재정적 투자는 제조업체의 발목을 잡을 수 있습니다. 위 슬리브 수술, 위 우회술, 위 밴드 조정술과 같은 수술의 높은 비용도 시장 성장을 제한할 수 있습니다. 이러한 고가의 수술에 대한 충분한 재정적 지원이 없기 때문에 특히 의료 자금이 제한된 지역에서 비만 수술 기기의 도입이 제한 될 수 있습니다.

본 보고서에서 다루는 주요 질문들

• 세계 비만 수술 기기 시장의 성장을 촉진하는 주요 요인은 무엇인가?
• 비만 수술 기기 채택을 주도하는 소비자층은?
• 수술 기술의 발전은 경쟁 상황에 어떤 영향을 미쳤습니까?
• 세계 비만 수술 기기 시장에서 주요 기업은 어디이며, 시장 지위를 유지하기 위해 어떤 전략을 취하고 있는가?
• 세계 비만 수술 기기 시장의 새로운 트렌드와 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 부가가치 인사이트

• 생산 전략
• 볼륨 소비
• 생산 비용
• 파이프라인 평가
• 특허 분석
• PESTEL 분석
• Porters 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
• 2024년 시장 시나리오

제7장 세계 시장(수량) 분석

• 시장(수량) 분석, 2019-2023년
• 시장(수량) 예측, 2024-2033년
  • 전년비 성장 동향 분석

제8장 세계 시장 - 가격 분석

• 의료기기/임플란트별 지역별 가격 분석
• 가격 내역
  • 제조업체 레벨
  • 유통업체 레벨
• 세계 평균 가격 분석 벤치마크
• 가격 설정 가정

제9장 세계 시장 수요(금액 및 규모) 분석

• 시장(금액) 분석, 2019-2023년
• 시장(금액) 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회

제10장 의료기기/임플란트별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액 및 수량) 분석, 2019-2023년
• 시장 규모(금액 및 수량) 분석과 예측, 2024-2033년
  • 위풍선
  • 위밴드
  • 스테이플 디바이스
• 의료기기·임플란트별 시장 매력 분석

제11장 최종사용자별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 병원
  • 전문 클리닉
  • 외래 수술 센터
• 최종사용자별 시장 매력 분석

제12장 지역별 : 세계 시장 분석

• 소개
• 시장 규모(금액 및 수량) 분석, 2019-2023년
• 시장 규모(금액 및 수량) 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 지역별 시장 매력 분석

제13장 북미 시장 분석

제14장 라틴아메리카 시장 분석

제15장 유럽 시장 분석

제16장 동아시아 시장 분석

제17장 남아시아 시장 분석

제18장 오세아니아 시장

제19장 중동 및 아프리카(MEA) 시장 분석

제20장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마크
• 경쟁 상세
  • Johnson & Johnson
  • Medtronic, Inc.
  • Apollo Endosurgery Inc.
  • Aspire Bariatrics
  • Spatz FGIA Inc.
  • MetaCure
  • IntraPace Inc.
  • Other

제22장 사용되는 가정과 두문자어

제23장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently published an in-depth report on the global obesity surgery devices market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a thorough understanding of the market structure and future outlook, catering to the needs of industry stakeholders looking to stay ahead in a competitive landscape.

Key Insights:

• Global Market Revenue (2022): US$ 1.9 Billion
• Estimated Market Value (2033): US$ 3.2 Billion
• Global Market Growth Rate (CAGR 2022-2033): 6.0%

Global Obesity Surgery Devices Market - Report Scope:

The obesity surgery devices market focuses on the production and distribution of devices used in surgical procedures aimed at treating obesity. These devices are critical in managing the increasing global prevalence of obesity, particularly in children and adults, and are integral to the healthcare sector's response to obesity-related health issues such as diabetes, cardiovascular diseases, and certain cancers.

Market Growth Drivers:

Increasing Incidence of Obesity in Children and Adults

The rising prevalence of obesity among children and adults worldwide is a significant factor driving the demand for obesity surgery devices. Poor dietary habits and reduced physical activity are leading to a surge in obesity rates, which is expected to remain a key driver of market growth. For instance, according to UNICEF's World Obesity Atlas for 2022, by 2030, more than 27 million children in India alone are expected to be obese. This alarming statistic underscores the growing need for effective obesity management strategies, fueling the global market for obesity surgery devices.

Rising Healthcare Spending and Awareness

As healthcare costs rise globally, particularly in emerging and developed economies, there is an increasing emphasis on obesity management and treatment. Higher per capita healthcare spending is anticipated to drive the adoption of advanced obesity surgery devices, as individuals and healthcare providers seek high-quality treatment options. Moreover, growing awareness among overweight individuals about the severe health risks associated with obesity, such as diabetes, cardiovascular diseases, and strokes, is expected to boost the demand for obesity surgery devices.

Government Campaigns and Minimally Invasive Procedures

Government-led campaigns to raise awareness about obesity and its consequences are also contributing to market growth. Initiatives like the LaparoObeso Centre's project in India, supported by the Maharashtra State Government, aim to educate remote populations about obesity and diabetes. Similarly, in China, the Obesity Prevention and Control Section of the Chinese Nutrition Society has launched awareness campaigns to address the obesity crisis. Additionally, the increasing preference for minimally invasive weight loss procedures is expected to further propel the market.

Market Challenges:

High Production Costs and Limited Financial Support

Despite the market's potential, the high cost of research, development, and production of obesity surgery devices poses a significant challenge. The substantial financial investment required for R&D activities, including clinical trials, can be a deterrent for manufacturers. The high cost of surgical procedures, such as gastric sleeve surgery, gastric bypass surgery, and adjustable gastric banding, may also limit market growth. The lack of adequate financial support for these expensive surgeries can restrict the adoption of obesity surgery devices, particularly in regions with limited healthcare funding.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global obesity surgery devices market?
• Which consumer segments are leading the adoption of obesity surgery devices?
• How are advancements in surgical technology influencing the competitive landscape?
• Who are the key players in the global obesity surgery devices market, and what strategies are they employing to maintain their market position?
• What are the emerging trends and future prospects in the global obesity surgery devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global obesity surgery devices market are focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a competitive edge. Companies are investing heavily in R&D to develop next-generation devices that offer improved safety, efficacy, and patient outcomes. Collaborations with healthcare providers and government agencies are enhancing market credibility and driving the adoption of these advanced surgical devices. Additionally, leveraging digital marketing and targeted outreach to both healthcare professionals and patients is key to strengthening market positioning and consumer engagement.

Key Companies Profiled:

• Johnson & Johnson
• Medtronic, Inc.
• Apollo Endosurgery Inc.
• Aspire Bariatrics
• Spatz FGIA Inc.
• MetaCure
• IntraPace Inc.
• Other

Key Segments Covered in Obesity Surgery Devices Industry Research

Medical Devices/ Implants:

• Gastric Balloons
• Gastric Bands
• Stapling Devices

End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage/Taxonomy
• 2.2. Market Definition/Scope/Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation/Development Trends

4. Value Added Insights

• 4.1. Production Strategy
• 4.2. Volume Consumption
• 4.3. Production Cost
• 4.4. Pipeline Assessment
• 4.5. Patent Analysis
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Technological Innovation in Surgery Devices
  • 5.2.2. Regulatory Imposition
  • 5.2.3. Increasing Spending on Research and Development
  • 5.2.4. Increasing Prevalence of Obesity
  • 5.2.5. Increasing Chronic Diseases Due to Obesity
  • 5.2.6. High Rate of Manufacturing
  • 5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
• 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume (Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

• 8.1. Regional Pricing Analysis By Medical Devices/Implants
• 8.2. Price Break up
  • 8.2.1. Manufacturer Level
  • 8.2.2. Distributor Level
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Medical Devices/Implants

• 10.1. Introduction/Key Findings
• 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Medical Devices/Implants, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Medical Devices/Implants, 2024-2033
  • 10.3.1. Gastric Balloons
  • 10.3.2. Gastric Bands
  • 10.3.3. Stapling Devices
• 10.4. Market Attractiveness Analysis By Medical Devices/Implants

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 11.1. Introduction/Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
  • 11.3.1. Hospitals
  • 11.3.2. Specialty Clinics
  • 11.3.3. Ambulatory Surgical Centers
• 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
• 12.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. East Asia
  • 12.3.5. South Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Medical Devices/Implants
  • 13.3.3. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Medical Devices/Implants
  • 13.4.3. By End User
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Players - Intensity Mapping
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. U.S. Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Medical Devices/Implants
      • 13.8.1.2.2. By End User
  • 13.8.2. Canada Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Medical Devices/Implants
      • 13.8.2.2.2. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Mexico
    • 14.3.1.2. Brazil
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Medical Devices/Implants
  • 14.3.3. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Medical Devices/Implants
  • 14.4.3. By End User
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Mexico Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Medical Devices/Implants
      • 14.8.1.2.2. By End User
  • 14.8.2. Brazil Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Medical Devices/Implants
      • 14.8.2.2.2. By End User
  • 14.8.3. Argentina Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Medical Devices/Implants
      • 14.8.3.2.2. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Medical Devices/Implants
  • 15.3.3. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Medical Devices/Implants
  • 15.4.3. By End User
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Germany Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Medical Devices/Implants
      • 15.8.1.2.2. By End User
  • 15.8.2. Italy Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Medical Devices/Implants
      • 15.8.2.2.2. By End User
  • 15.8.3. France Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Medical Devices/Implants
      • 15.8.3.2.2. By End User
  • 15.8.4. U.K. Market Analysis
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Medical Devices/Implants
      • 15.8.4.2.2. By End User
  • 15.8.5. Spain Market Analysis
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Medical Devices/Implants
      • 15.8.5.2.2. By End User
  • 15.8.6. BENELUX Market Analysis
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Medical Devices/Implants
      • 15.8.6.2.2. By End User
  • 15.8.7. Russia Market Analysis
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Medical Devices/Implants
      • 15.8.7.2.2. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Medical Devices/Implants
  • 16.3.3. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Medical Devices/Implants
  • 16.4.3. By End User
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. China Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Medical Devices/Implants
      • 16.8.1.2.2. By End User
  • 16.8.2. Japan Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Medical Devices/Implants
      • 16.8.2.2.2. By End User
  • 16.8.3. South Korea Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Medical Devices/Implants
      • 16.8.3.2.2. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Medical Devices/Implants
  • 17.3.3. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Medical Devices/Implants
  • 17.4.3. By End User
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. India Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Medical Devices/Implants
      • 17.8.1.2.2. By End User
  • 17.8.2. Indonesia Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Medical Devices/Implants
      • 17.8.2.2.2. By End User
  • 17.8.3. Malaysia Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Medical Devices/Implants
      • 17.8.3.2.2. By End User
  • 17.8.4. Thailand Market Analysis
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Medical Devices/Implants
      • 17.8.4.2.2. By End User

18. Oceania Market 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Medical Devices/Implants
  • 18.3.3. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Medical Devices/Implants
  • 18.4.3. By End User
• 18.5. Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Players - Intensity Mapping
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. Australia Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Medical Devices/Implants
      • 18.8.1.2.2. By End User
  • 18.8.2. New Zealand Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Medical Devices/Implants
      • 18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkiye
    • 19.3.1.3. North Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Medical Devices/Implants
  • 19.3.3. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Medical Devices/Implants
  • 19.4.3. By End User
• 19.5. Market Trends
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Players - Intensity Mapping
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. GCC Countries Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Medical Devices/Implants
      • 19.8.1.2.2. By End User
  • 19.8.2. Turkiye Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Medical Devices/Implants
      • 19.8.2.2.2. By End User
  • 19.8.3. South Africa Market Analysis
    • 19.8.3.1. Introduction
    • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.3.2.1. By Medical Devices/Implants
      • 19.8.3.2.2. By End User
  • 19.8.4. North Africa Market Analysis
    • 19.8.4.1. Introduction
    • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.4.2.1. By Medical Devices/Implants
      • 19.8.4.2.2. By End User

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Johnson & Johnson
    • 21.3.1.1. Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Sales Footprint
    • 21.3.1.4. Key Financials
    • 21.3.1.5. SWOT Analysis
    • 21.3.1.6. Strategy Overview
  • 21.3.2. Medtronic, Inc.
    • 21.3.2.1. Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Sales Footprint
    • 21.3.2.4. Key Financials
    • 21.3.2.5. SWOT Analysis
    • 21.3.2.6. Strategy Overview
  • 21.3.3. Apollo Endosurgery Inc.
    • 21.3.3.1. Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Sales Footprint
    • 21.3.3.4. Key Financials
    • 21.3.3.5. SWOT Analysis
    • 21.3.3.6. Strategy Overview
  • 21.3.4. Aspire Bariatrics
    • 21.3.4.1. Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Sales Footprint
    • 21.3.4.4. Key Financials
    • 21.3.4.5. SWOT Analysis
    • 21.3.4.6. Strategy Overview
  • 21.3.5. Spatz FGIA Inc.
    • 21.3.5.1. Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Sales Footprint
    • 21.3.5.4. Key Financials
    • 21.3.5.5. SWOT Analysis
    • 21.3.5.6. Strategy Overview
  • 21.3.6. MetaCure
    • 21.3.6.1. Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Sales Footprint
    • 21.3.6.4. Key Financials
    • 21.3.6.5. SWOT Analysis
    • 21.3.6.6. Strategy Overview
  • 21.3.7. IntraPace Inc.
    • 21.3.7.1. Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Sales Footprint
    • 21.3.7.4. Key Financials
    • 21.3.7.5. SWOT Analysis
    • 21.3.7.6. Strategy Overview
  • 21.3.8. Other
    • 21.3.8.1. Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Sales Footprint
    • 21.3.8.4. Key Financials
    • 21.3.8.5. SWOT Analysis
    • 21.3.8.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료